Search results
Screening recommendations should be adapted based on anatomy, (i.e., annual, routine screening for chlamydia in cisgender women < 25 years old should be extended to all transgender men and gender diverse people with a cervix.
This 2021 Recommendation Statement from the US Preventive Services Task Force recommends that all sexually active women 24 years or younger and women 25 years or older at increased risk for infection be screened for chlamydia (B recommendation) and gonorrhea (B recommendation) and concludes that current evidence is insufficient to assess the ...
- Amy Cantor, Tracy Dana, Jessica C. Griffin, Heidi D. Nelson, Chandler Weeks, Kevin L. Winthrop, Roge...
- 2021
Sep 13, 2023 · Table 1 summarizes and compares CDC and USPSTF screening guidance for a subset of common STIs: chlamydia, gonorrhea, syphilis, and trichomoniasis. 2–4 In several instances, guidelines recommend basing the decision to screen or the frequency of screening on an assessment of STI risk.
Oct 28, 2021 · Screening recommendations for cisgender women regarding gonorrhea, chlamydia, and cervical cancer should be extended to all transgender men and gender-diverse people with a cervix. Screening at the pharyngeal and rectal sites for gonorrhea and chlamydia should be considered based on reported sexual behaviors and exposure.
Apr 1, 2015 · Screening for chlamydia has a moderate net benefit in females aged ≤ 24 y and older women at increased risk for infection.
Among women, the primary focus of chlamydia screening should be to detect and treat chlamydia, prevent complications, and test and treat their partners, whereas targeted chlamydia screening for men should be considered only when resources permit, prevalence is high, and such screening does not hinder chlamydia screening efforts for women (789 ...
The Task Force recommends screening all sexually active women and pregnant people age 24 years and younger for chlamydia and gonorrhea. Screening is also recommended for women and pregnant people age 25 years and older who are at increased risk for infection. These are B recommendations.
